Many of these AD-like pathologies and cognitive declines were first reported in tau-based NHP models for AD, and the accumulation of both 3R and 4R tau isoforms is an NHP-specific pathological feature that cannot be reproduced in rodent models for AD. This evidence concerns the gene MAPT and Alzheimer disease.